| The histone deacetylase inhibitor givinostat (ITF2357) exhibits potent anti-tumor activity against CRLF2-rearranged BCP-ALL AM Savino, J Sarno, L Trentin, M Vieri, G Fazio, M Bardini, C Bugarin, ... Leukemia 31 (11), 2365-2375, 2017 | 46 | 2017 |
| Comparison of flow‐FISH and MM–qPCR telomere length assessment techniques for the screening of telomeropathies MSV Ferreira, M Kirschner, I Halfmeyer, N Estrada, B Xicoy, S Isfort, ... Annals of the New York Academy of Sciences 1466 (1), 93-103, 2020 | 36 | 2020 |
| Epigenetic clocks are not accelerated in COVID-19 patients J Franzen, S Nüchtern, V Tharmapalan, M Vieri, M Nikolić, Y Han, ... International journal of molecular sciences 22 (17), 9306, 2021 | 34 | 2021 |
| PRDM8 reveals aberrant DNA methylation in aging syndromes and is relevant for hematopoietic and neuronal differentiation O Cypris, M Eipel, J Franzen, C Rösseler, V Tharmapalan, CC Kuo, ... Clinical epigenetics 12, 1-14, 2020 | 28 | 2020 |
| Androgen derivatives improve blood counts and elongate telomere length in adult cryptic dyskeratosis congenita M Kirschner, M Vieri, K Kricheldorf, MSV Ferreira, MW Wlodarski, ... British journal of haematology 193 (3), 669-673, 2021 | 23 | 2021 |
| Comparable effects of the androgen derivatives danazol, oxymetholone and nandrolone on telomerase activity in human primary hematopoietic cells from patients with dyskeratosis … M Vieri, M Kirschner, M Tometten, A Abels, B Rolles, S Isfort, J Panse, ... International Journal of Molecular Sciences 21 (19), 7196, 2020 | 23 | 2020 |
| Antileukemic Efficacy of BET Inhibitor in a Preclinical Mouse Model of MLL-AF4+ Infant ALL M Bardini, L Trentin, F Rizzo, M Vieri, AM Savino, P Garrido Castro, ... Molecular Cancer Therapeutics 17 (8), 1705-1716, 2018 | 22 | 2018 |
| Treatment of telomeropathies M Vieri, TH Bruemmendorf, F Beier Best Practice & Research Clinical Haematology 34 (2), 101282, 2021 | 19 | 2021 |
| Cytoskeletal regulatory gene expression and migratory properties of B-cell progenitors are affected by the ETV6–RUNX1 rearrangement C Palmi, G Fazio, AM Savino, J Procter, L Howell, V Cazzaniga, M Vieri, ... Molecular cancer research 12 (12), 1796-1806, 2014 | 15 | 2014 |
| Interstitial lung diseases associated with mutations of poly (A)‐specific ribonuclease: A multicentre retrospective study Q Philippot, C Kannengiesser, MP Debray, C Gauvain, I Ba, M Vieri, ... Respirology 27 (3), 226-235, 2022 | 11 | 2022 |
| Targeting autophagy increases the efficacy of proteasome inhibitor treatment in multiple myeloma by induction of apoptosis and activation of JNK A Salimi, KM Schroeder, M Schemionek-Reinders, M Vieri, S Maletzke, ... BMC cancer 22 (1), 735, 2022 | 9 | 2022 |
| Targeting of BCR-ABL1 and IRE1α induces synthetic lethality in Philadelphia-positive acute lymphoblastic leukemia M Vieri, C Preisinger, M Schemionek, A Salimi, JB Patterson, A Samali, ... Carcinogenesis 42 (2), 272-284, 2021 | 9 | 2021 |
| Telomere shortening in peripheral leukocytes is associated with poor survival in cancer patients treated with immune checkpoint inhibitor therapy B Rolles, J Gorgulho, M Tometten, C Roderburg, M Vieri, A Abels, ... Frontiers in Oncology 11, 729207, 2021 | 7 | 2021 |
| Targeting the angio-proteostasis network: Combining the forces against cancer L Devisscher, M Vieri, SE Logue, J Panse, A Geerts, H Van Vlierberghe, ... Pharmacology & Therapeutics 167, 1-12, 2016 | 7 | 2016 |
| Identification of adult patients with classical dyskeratosis congenita or cryptic telomere biology disorder by telomere length screening using age-modified criteria M Tometten, M Kirschner, R Meyer, M Begemann, I Halfmeyer, M Vieri, ... HemaSphere 7 (5), e874, 2023 | 3 | 2023 |
| Impaired overall survival in young patients with acute myeloid leukemia and variants in genes predisposing for myeloid Malignancies M Kirschner, B Rolles, M Crysandt, C Röllig, F Stölzel, M Kramer, ... HemaSphere 6 (11), e787, 2022 | 3 | 2022 |
| Synergistic Dual Inhibition of BCR-ABL1 and the Unfolded Protein Response Causes p38 MAPK-Mediated Cell Death and Sensitizes BCR-ABL1+ Acute Lymphoblastic Leukemia to Dexamethasone M Vieri, C Preisinger, M Schemionek, A Salimi, JB Patterson, A Samali, ... Blood 132, 4674, 2018 | 3 | 2018 |
| Role of the histone deacetylase inhibitor givinostat (ITF2357) in treatment of CRLF2 rearranged acute lymphoblastic leukemia AM Savino, J Sarno, L Trentin, M Vieri, G Fazio, M Bardini, C Bugarin, ... Blood 126 (23), 2534, 2015 | 2 | 2015 |
| Cellular aging is accelerated in the malignant clone of myeloproliferative neoplasms M Vieri, V Tharmapalan, M Kalmer, J Baumeister, M Nikolić, M Schnitker, ... Blood Cancer Journal 13 (1), 164, 2023 | 1 | 2023 |
| XBP1 promotes NRASG12D pre‐B acute lymphoblastic leukaemia through IL‐7 receptor signalling and provides a therapeutic vulnerability for oncogenic RAS A Salimi, M Schemionek‐Reinders, M Huber, M Vieri, JB Patterson, ... Journal of Cellular and Molecular Medicine 27 (21), 3363-3377, 2023 | 1 | 2023 |
